Small bowel adenocarcinoma: natural history of recurrence after surgical resection

Abstract

Small bowel adenocarcinomas (SBA) are a rare entity associated with a poor prognosis and an advanced stage of disease at diagnosis. Surgical resection is considered the gold standard of treatment for stage I-III, while stage IV disease approach is still debated. We present a case of a young woman affected by a duodenojejunal junction SBA treated with surgical resection and FOLFOX adjuvant chemotherapy. The patient later underwent a palliative duodenojejunal bypass for peritoneal carcinomatosis.

Unusual presentation of jejunal adenocarcinoma and ovarian metastasis

“…Three to five percent of malignant tumors of the intestinal tract are found in the small bowel. Small bowel adenocarcinoma is an extremely rare condition (30-40 % of malignant tumors in this location) (3). It is normally diagnosed in advanced stages, thus indicating poor clinical outcome.…”